批处理可以通过CAS号，CAS号，每行一个搜索
| 别名 | Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine;GW2016 LAPATINIB;GW-572016;TYKERB;lapatinib;n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-;Lapatinib(TINIBS);GW572016;Lapatinib ( GSK572016,GW2016,GW-572016);Lapatinib base;4-{[3-chloro-4-(3-fluoro-benzyloxy)-phenyl]amino}-6-(5-{[(2-methanesulphonyl-ethyl)amino]methyl}-furan-2-yl)quinazoline;4-{[3-chloro-4-(3-fluoro-benzyloxy)-phenyl]amino}-6-(5-{[(2-methansulfonyl-ethyl)amino]methyl}-furan-2-yl)quinazoline;N-{3-Chloro-4-[(3-fluorobenzyl) oxy]phenyl}-6-[5-({[2-(methanesulphonyl) ethyl]amino}methyl)-2-furyl]-4-quinazolinamine;N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethy;GW 572016;Lapatinib tosilate hydrate;Lapatinib [INN];Tyverb;Lapatinib (INN);Lapatinib free base;GSK 572016;GSK572016;FMM;N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE;0VUA21238F;NSC745750;C29H26ClFN4O4S;DSSTox_RID_81812;DSSTox_CID_26675;DSSTox_GSID_46675;N-{3-chloro-4-[(3-fluorophenyl)me | ||
| CAS号 | 231277-92-2 | 产品编号 | HZ996 |
| 分子式 | C29H26ClFN4O4S | 分子量 | 581.06 |
| EINECS号 | MDL号 | ||
